Anyone selling today hasn't read the results of a study which was posted yesterday by Toronumerouno
BACKGROUND:Chimeric antigen receptor (CAR) T cells targeting the B-cell antigen CD19 are standard therapy for relapsed or refractory B-cell lymphoma and leukemia. CAR T cell therapy in solid tumors is limited due to an immunosuppressive tumor microenvironment and a lack of tumor-restricted antigens. We recently engineered an oncolytic virus (CF33) with high solid tumor affinity and specificity to deliver a nonsignaling truncated CD19 antigen (CD19t), allowing targeting by CD19-CAR T cells. Here, we tested this combination against pancreatic cancer.
STUDY DESIGN:
We engineered CF33 to express a CD19t (CF33-CD19t) target. Flow cytometry and ELISA were performed to quantify CD19t expression, immune activation, and killing by virus and CD19-CAR T cells against various pancreatic tumor cells. Subcutaneous pancreatic human xenograft tumor models were treated with virus, CAR T cells, or virus+CAR T cells.
RESULTS:
In vitro, CF33-CD19t infection of tumor cells resulted in >90% CD19t cell-surface expression. Coculturing CD19-CAR T cells with infected cells resulted in interleukin-2 and interferon gamma secretion, upregulation of T-cell activation markers, and synergistic cell killing. Combination therapy of virus+CAR T cells caused significant tumor regression (day 13): control (n = 16, 485 ± 20 mm3), virus alone (n = 20, 254 ± 23 mm3, p = 0.0001), CAR T cells alone (n = 18, 466 ± 25 mm3, p = NS), and virus+CAR T cells (n = 16, 128 ± 14 mm3, p < 0.0001 vs control; p = 0.0003 vs virus).
CONCLUSIONS:
Engineered CF33-CD19t effectively infects and expresses CD19t in pancreatic tumors, triggering cell killing and increased immunogenic response by CD19-CAR T cells. Notably, CF33-CD19t can turn cold immunologic tumors hot, enabling solid tumors to be targetable by agents designed against liquid tumor antigens.
https://journals.lww.com/journalacs/abstract/2024/04000/using_oncolytic_virus_to_retask_cd19_chimeric.14.aspx
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-12505
-
- There are more pages in this discussion • 1,486 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.1¢ |
Change
0.001(1.67%) |
Mkt cap ! $446.5M |
Open | High | Low | Value | Volume |
6.0¢ | 6.3¢ | 5.8¢ | $1.661M | 27.74M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 513999 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 51941 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 513999 | 0.061 |
11 | 998194 | 0.060 |
9 | 968491 | 0.059 |
12 | 1283310 | 0.058 |
10 | 1089599 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.062 | 51941 | 2 |
0.063 | 688842 | 8 |
0.064 | 100000 | 1 |
0.065 | 889345 | 8 |
0.066 | 539500 | 3 |
Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
6.2¢ |
  |
Change
0.001 ( 4.38 %) |
|||
Open | High | Low | Volume | ||
6.0¢ | 6.2¢ | 5.8¢ | 10422066 | ||
Last updated 15.59pm 05/06/2024 ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online